Intraduodenal infusion of a water-based levodopa dispersion for optimisation of the therapeutic effect in severe Parkinson's disease
- 1 September 1993
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Pharmacology
- Vol. 45 (2), 117-122
- https://doi.org/10.1007/bf00315491
Abstract
Motor performance of five patients with advanced Parkinson's disease was investigated during their optimum oral therapy (conventional tablets and/or depot capsules) and during a continuous duodenal infusion of levodopa. Due to the low water solubility of the drug, conventional tablets of levodopa + carbidopa (Sinemet®) were milled and dispersed in a 1.8% aqueous methylcellulose solution. The dispersion was delivered nasoduodenally by a portable pump. The effect of levodopa in the two dosing regimens was estimated optico-electronically every 15 min and was also evaluated from videorecordings every 30 min and plasma levels of levodopa was regularly measured. Each dosage regimen the was studied twice, at a 2–4 day interval. Duodenal infusion improved motor function in all five patients and the fluctuations were reduced when compared to the oral therapy. Variation in plasma levodopa concentrations was 3–10 fold during oral therapy, while during the infusion a stable concentration was obtained. The therapeutic concentration varied from 0.3–3 μg ml−1 between patients. The relative bioavailability of levodopa in the solid preparation compared to the dispersion was in all patients 100%. Our results encourage further development of a duodenal infusion system with a levodopa dispersion for clinical use in parkinsonian patients who show severe fluctuation.Keywords
This publication has 18 references indexed in Scilit:
- Clinical and pharmacokinetic comparison of oral and duodenal delivery of levodopa/carbidopa in patients with Parkinson's disease with a fluctuating response to levodopaEuropean Journal of Clinical Pharmacology, 1991
- Pharmacokinetics and effects of levodopa in advanced Parkinson's diseaseEuropean Journal of Clinical Pharmacology, 1990
- Sustained enteral administration of levodopa increases and interrupted infusion decreases levodopa dose requirementNeurology, 1990
- Disability profiles and objective quantitative assessment in Parkinson's diseaseActa Neurologica Scandinavica, 1989
- Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, Part IAnnals of Neurology, 1988
- Duodenal and gastric delivery of levodopa in parkinsonismAnnals of Neurology, 1988
- Erratic gastric emptying of levodopa may cause “random” fluctuations of parkinsonian mobilityNeurology, 1988
- Duodenal delivery of levodopa for on‐off fluctuations in parkinsonism: Preliminary observationsAnnals of Neurology, 1986
- Simultaneous assay of 3,4-dihydroxyphenylalanine, catecholamines and O-methylated metabolites in human plasma using high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1984
- ParkinsonismNeurology, 1967